Replimune (REPL) stock is in focus as the FDA agreed to have a third look at the company's lead drug for melanoma after White House intervention. Read more here.
Start Your NewsReadery Pro FREE TRIAL!
| | |
#wallstreetjournal
Short-lived Project Freedom cleared a "relatively safe path" for ships through the Iranian blockade, and some reportedly stay in contact with U.S. military officials to navigate through unscathed while turning off lights and beacons.
White House proposes stiffer regional requirements under USMCA -- WSJ
The lawsuit is one of several that the president has brought in his personal capacity against news organizations ...
Legal action claims newspaper tarnished reputation by describing card to Jeffrey Epstein as bearing his signature ...
A federal judge dismissed the case last month, concluding that Trump failed to allege "actual malice," a standard that public figures must demonstrate in defamation cases.
U.S. consumer sentiment hits record lows as the S&P 500 rallies on AI hopes and high valuations.
IMAX stock jumped 15% as WSJ says it's exploring a sale. See likely buyers--Apple, Sony, Netflix--plus antitrust risks and price targets.
Binance rejects WSJ claims linking it to Iran-related transactions, saying the report misrepresents activity and compliance actions.
Binance CEO Richard Teng refutes WSJ claims about Iran-linked crypto flows, stating transactions occurred before sanctions with full compliance oversight.